Abstract
Peroxisome Proliferator-activated Receptors (PPARs) are transcription factors that play a major role in glucose and lipid metabolism. As other proteins from the nuclear receptor superfamily, the transcription activity of PPARs is regulated by the binding of endogenous or synthetic ligands, being attractive targets for development of antidiabetic and/or antilipidemic drugs. Recent studies …